THE DOPAMINE D3 ANTAGONIST SB-27701A ABOLISHES PTSD-LIKE SYMPTOMS IN MALE C57BL/J6 MICE

Department, Center, or Institute

Psychology

Secondary Department, Center, or Institute

Neuroscience

Presentation Format

Poster

Presentation Type

On-campus research

Description

Post-traumatic stress disorder (PTSD) is a widely known mental disorder that causes deficits to pathways in the brain. The D3 receptor in the mesolimbic dopamine pathway is linked to the development of PTSD in both rodents and humans. We used the single prolonged stress (SPS) model to induce PTSD-like symptoms in male C57BL/J6 mice. During the model, animals were injected (i.p.) with SB-27701A, a D3 antagonist. A high dose of D3 antagonist removed PTSD-like symptoms in mice, which suggest that antagonization of the D3 receptor can abolish PTSD-like symptoms in male C57BL/J6 mice.

Session Number

5

Start Date and Time

4-9-2019 4:00 PM

Location

PAC Gym

This document is currently not available here.

Share

COinS
 
Apr 9th, 4:00 PM

THE DOPAMINE D3 ANTAGONIST SB-27701A ABOLISHES PTSD-LIKE SYMPTOMS IN MALE C57BL/J6 MICE

PAC Gym

Post-traumatic stress disorder (PTSD) is a widely known mental disorder that causes deficits to pathways in the brain. The D3 receptor in the mesolimbic dopamine pathway is linked to the development of PTSD in both rodents and humans. We used the single prolonged stress (SPS) model to induce PTSD-like symptoms in male C57BL/J6 mice. During the model, animals were injected (i.p.) with SB-27701A, a D3 antagonist. A high dose of D3 antagonist removed PTSD-like symptoms in mice, which suggest that antagonization of the D3 receptor can abolish PTSD-like symptoms in male C57BL/J6 mice.